Guided Therapeutics (GTHP) Invested Capital (2016 - 2025)
Guided Therapeutics' Invested Capital history spans 16 years, with the latest figure at -$5.4 million for Q4 2025.
- On a quarterly basis, Invested Capital fell 25.21% to -$5.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$5.4 million, a 25.21% decrease, with the full-year FY2025 number at -$5.4 million, down 25.21% from a year prior.
- Invested Capital hit -$5.4 million in Q4 2025 for Guided Therapeutics, down from -$5.0 million in the prior quarter.
- Over the last five years, Invested Capital for GTHP hit a ceiling of -$2.1 million in Q3 2022 and a floor of -$7.9 million in Q1 2021.
- Historically, Invested Capital has averaged -$4.5 million across 5 years, with a median of -$4.4 million in 2024.
- Biggest five-year swings in Invested Capital: surged 70.38% in 2022 and later crashed 50.27% in 2023.
- Tracing GTHP's Invested Capital over 5 years: stood at -$5.4 million in 2021, then soared by 57.66% to -$2.3 million in 2022, then tumbled by 41.81% to -$3.3 million in 2023, then tumbled by 31.45% to -$4.3 million in 2024, then dropped by 25.21% to -$5.4 million in 2025.
- Business Quant data shows Invested Capital for GTHP at -$5.4 million in Q4 2025, -$5.0 million in Q3 2025, and -$4.9 million in Q2 2025.